Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) EBT: 2022-2025

Historic EBT for Abivax (ABVX) over the last 1 years, with Jun 2025 value amounting to -$54.8 million.

  • Abivax's EBT fell 31.26% to -$54.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$151.6 million, marking a year-over-year decrease of 71.69%. This contributed to the annual value of -$188.3 million for FY2024, which is 18.48% down from last year.
  • According to the latest figures from Q2 2025, Abivax's EBT is -$54.8 million, which was up 0.52% from -$55.1 million recorded in Q1 2025.
  • Abivax's 5-year EBT high stood at -$66.11 for Q4 2022, and its period low was -$55.1 million during Q1 2025.
  • Moreover, its 3-year median value for EBT was -$44.2 million (2024), whereas its average is -$33.0 million.
  • Data for Abivax's EBT shows a maximum YoY crashed of 107.34% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Abivax's EBT stood at -$66.11 in 2022, then tumbled by 107.34% to -$137.07 in 2023, then slumped by 34.79% to -$184.76 in 2024, then crashed by 31.26% to -$54.8 million in 2025.
  • Its EBT stands at -$54.8 million for Q2 2025, versus -$55.1 million for Q1 2025 and -$184.76 for Q4 2024.